Wu, Yike
Hu, Linghui
Huang, Jianlin
Zhong, Yunxue
Li, Kangcheng
Qiu, Zhou
Su, Li
Zhang, Yuan
Liu, Wenlan
Funding for this research was provided by:
Shenzhen Science and Technology Program (JCYJ20240813144014019)
Shenzhen Science and Technology Program (JCYJ20230807115310022)
National Natural Science Foundation of China (82371423)
Guangdong Province Basic and Applied Basic Research Project (2024A1515010706)
Guangdong Province Basic and Applied Basic Research Project (2021B1515120051, 2022A1515010466)
Shenzhen Basic Discipline Layout Project (JCYJ20210324115601005)
Guangdong Innovation Platform for Translational Medicine in Cerebrovascular Disease
Article History
Received: 27 June 2025
Accepted: 5 December 2025
First Online: 28 January 2026
Declarations
:
: The study was carried out in accordance with the Helsinki Declaration and informed consents were obtained from the participants in accordance with the study protocols approved by the Ethics Committee of Shenzhen Second People’s Hospital and China Technology Industry Holdings (Shenzhen) Co., LTD (202400118 and 20181106007).
: Not applicable.
: The authors declare no competing interests.